Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Neuroendocrine Cancer Headlining the News

Neuroendocrine Cancer Headlining the News

NOVEMBER 2024 01/11/2024 Urgent action needed to improve the survival rate of people with rare cancers, campaigners say Campaigners highlight the urgent need for improved diagnosis and care for rare cancers like neuroendocrine cancer – read Dave's story and the call...

read more
PERT Update

PERT Update

As some of you may be aware, we are working with fellow charities and patient organisations to ‘lobby’ and work with the government and other stakeholders to better address PERT shortages. Our working group of charities and patient organisations meets monthly, and...

read more